Linked Life Data

11266180

Source:http://linkedlifedata.com/resource/pubmed/id/11266180

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-3-26
pubmed:abstractText
Factor Xa, a critical serine protease in the blood coagulation cascade, has become a target for inhibition as a strategy for the invention of novel anti-thrombotic agents. Here we describe the development of phenylglycine containing benzamidine carboxamides as novel, potent and selective inhibitors of factor Xa.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
733-6
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
The design of phenylglycine containing benzamidine carboxamides as potent and selective inhibitors of factor Xa.
pubmed:affiliation
Prosthetics Molecular Design, Beechfield House, Macclesfield, UK. stuart.jones@protherics.com
pubmed:publicationType
Journal Article